DK38984D0 - Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker pa centralnervesystemet, fremgangsmade til fremstilling heraf og laegemidler med indhold heraf - Google Patents
Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker pa centralnervesystemet, fremgangsmade til fremstilling heraf og laegemidler med indhold herafInfo
- Publication number
- DK38984D0 DK38984D0 DK0389/84A DK38984A DK38984D0 DK 38984 D0 DK38984 D0 DK 38984D0 DK 0389/84 A DK0389/84 A DK 0389/84A DK 38984 A DK38984 A DK 38984A DK 38984 D0 DK38984 D0 DK 38984D0
- Authority
- DK
- Denmark
- Prior art keywords
- procedures
- amino
- impact
- manufacturing
- nervous system
- Prior art date
Links
- -1 AMINO Chemical group 0.000 title 1
- 210000003169 central nervous system Anatomy 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8301234A FR2540113A1 (fr) | 1983-01-27 | 1983-01-27 | Acides derives de la pyridazine actifs sur le systeme nerveux central |
| FR8301234 | 1983-01-27 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK38984D0 true DK38984D0 (da) | 1984-01-27 |
| DK38984A DK38984A (da) | 1984-07-28 |
| DK162985B DK162985B (da) | 1992-01-06 |
| DK162985C DK162985C (da) | 1992-06-01 |
Family
ID=9285330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK038984A DK162985C (da) | 1983-01-27 | 1984-01-27 | Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker paa centralnervesystemet, fremgangsmaade til fremstilling heraf og laegemidler med indhold heraf |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4721711A (da) |
| EP (1) | EP0117779B1 (da) |
| JP (1) | JPS59141564A (da) |
| KR (1) | KR910000638B1 (da) |
| AR (1) | AR240045A1 (da) |
| AT (1) | ATE48417T1 (da) |
| AU (2) | AU2372984A (da) |
| CA (1) | CA1238637A (da) |
| DD (1) | DD220026A5 (da) |
| DE (1) | DE3480653D1 (da) |
| DK (1) | DK162985C (da) |
| ES (1) | ES529081A0 (da) |
| FI (1) | FI78691C (da) |
| FR (1) | FR2540113A1 (da) |
| HU (1) | HU193890B (da) |
| IE (1) | IE57054B1 (da) |
| IL (1) | IL70756A (da) |
| MA (1) | MA20018A1 (da) |
| NO (1) | NO840313L (da) |
| NZ (1) | NZ206945A (da) |
| OA (1) | OA07644A (da) |
| PH (1) | PH21162A (da) |
| PL (1) | PL142340B1 (da) |
| PT (1) | PT77993B (da) |
| SG (1) | SG93690G (da) |
| YU (1) | YU14284A (da) |
| ZA (1) | ZA84502B (da) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2540113A1 (fr) * | 1983-01-27 | 1984-08-03 | Sanofi Sa | Acides derives de la pyridazine actifs sur le systeme nerveux central |
| DE3664772D1 (en) * | 1985-01-14 | 1989-09-07 | Boehringer Ingelheim Kg | 12-amino pyridazinoû4',5':3,4¨pyrroloû2,1-a¨isoquinolines, process for their preparation and use |
| US5082939A (en) * | 1987-01-08 | 1992-01-21 | I.S.F. Societa Per Azioni | Pyridazine derivatives |
| US5106973A (en) * | 1987-11-23 | 1992-04-21 | Janssen Pharmaceutica N.V. | Pyridzainamine derivatives |
| FR2663326B2 (fr) * | 1989-11-17 | 1992-10-16 | Sanofi Sa | Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant. |
| US5631255A (en) * | 1989-02-07 | 1997-05-20 | Sanofi | Pyridazine derivatives |
| FR2668151A1 (fr) * | 1990-10-23 | 1992-04-24 | Rhone Poulenc Agrochimie | Composes a groupe triazolopyridazine leurs preparations et compositions herbicides les contenant. |
| FR2676444B1 (fr) * | 1991-05-16 | 1995-03-10 | Sanofi Elf | Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant. |
| CN1038249C (zh) * | 1991-08-28 | 1998-05-06 | 罗姆和哈斯公司 | 含有二氢哒嗪酮及其相关化合物的杀菌组合物 |
| US20100210590A1 (en) * | 1995-09-27 | 2010-08-19 | Northwestern University | Compositions and treatments for seizure-related disorders |
| US20030176437A1 (en) * | 2001-08-31 | 2003-09-18 | D.M. Watterson | Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| BRPI0517947A (pt) | 2004-11-02 | 2008-10-21 | Univ Northwestern | composto de piridazina, composições e métodos |
| ATE523199T1 (de) * | 2004-11-02 | 2011-09-15 | Univ Northwestern | Pyridazinverbindungen und verfahren |
| US20100168120A1 (en) * | 2006-04-28 | 2010-07-01 | Neuromedix Inc. | Salts of pyridazine compounds |
| CA2650711A1 (en) * | 2006-04-28 | 2007-11-08 | Northwestern University | Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
| JP2009535344A (ja) | 2006-04-28 | 2009-10-01 | ノースウェスタン ユニバーシティ | 神経炎症性疾患の処置のためのピリダジン化合物を含む処方物 |
| EP2142498A2 (en) * | 2007-04-02 | 2010-01-13 | Institute for Oneworld Health | Cftr inhibitor compounds and uses thereof |
| EP2278879B1 (en) | 2008-04-21 | 2016-06-15 | PATH Drug Solutions | Compounds, compositions and methods comprising oxadiazole derivatives |
| WO2009131958A2 (en) * | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, compositions and methods comprising triazine derivatives |
| US20090270398A1 (en) * | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, Compositions and Methods Comprising Pyridazine Derivatives |
| US8236838B2 (en) * | 2008-04-21 | 2012-08-07 | Institute For Oneworld Health | Compounds, compositions and methods comprising isoxazole derivatives |
| JP2012503005A (ja) * | 2008-09-19 | 2012-02-02 | インスティテュート フォア ワンワールド ヘルス | イミダゾール誘導体およびトリアゾール誘導体を含む、化合物、組成物ならびに方法。 |
| US8343976B2 (en) * | 2009-04-20 | 2013-01-01 | Institute For Oneworld Health | Compounds, compositions and methods comprising pyrazole derivatives |
| US20100267706A1 (en) * | 2009-04-20 | 2010-10-21 | Institute For Oneworld Health | Compounds, Compositions and Methods Comprising Pyridazine Derivatives |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2510998B1 (fr) * | 1981-08-07 | 1986-01-10 | Sanofi Sa | Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent |
| FR2510997A1 (fr) * | 1981-08-10 | 1983-02-11 | Sanofi Sa | Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant |
| FR2540113A1 (fr) * | 1983-01-27 | 1984-08-03 | Sanofi Sa | Acides derives de la pyridazine actifs sur le systeme nerveux central |
| US4565814A (en) * | 1983-01-28 | 1986-01-21 | Sanofi | Pyridazine derivatives having a psychotropic action and compositions |
-
1983
- 1983-01-27 FR FR8301234A patent/FR2540113A1/fr active Granted
-
1984
- 1984-01-18 CA CA000445481A patent/CA1238637A/en not_active Expired
- 1984-01-20 PH PH30135A patent/PH21162A/en unknown
- 1984-01-20 AR AR295532A patent/AR240045A1/es active
- 1984-01-23 PT PT77993A patent/PT77993B/pt not_active IP Right Cessation
- 1984-01-23 ES ES529081A patent/ES529081A0/es active Granted
- 1984-01-23 IL IL70756A patent/IL70756A/xx unknown
- 1984-01-23 ZA ZA84502A patent/ZA84502B/xx unknown
- 1984-01-23 IE IE149/84A patent/IE57054B1/en not_active IP Right Cessation
- 1984-01-24 AU AU23729/84A patent/AU2372984A/en not_active Abandoned
- 1984-01-25 EP EP84400156A patent/EP0117779B1/fr not_active Expired
- 1984-01-25 DE DE8484400156T patent/DE3480653D1/de not_active Expired - Fee Related
- 1984-01-25 AT AT84400156T patent/ATE48417T1/de not_active IP Right Cessation
- 1984-01-26 FI FI840323A patent/FI78691C/fi not_active IP Right Cessation
- 1984-01-26 KR KR1019840000335A patent/KR910000638B1/ko not_active Expired
- 1984-01-26 OA OA58216A patent/OA07644A/xx unknown
- 1984-01-26 HU HU84331A patent/HU193890B/hu not_active IP Right Cessation
- 1984-01-26 NZ NZ206945A patent/NZ206945A/en unknown
- 1984-01-26 NO NO840313A patent/NO840313L/no unknown
- 1984-01-26 MA MA20239A patent/MA20018A1/fr unknown
- 1984-01-26 DD DD84259650A patent/DD220026A5/de not_active IP Right Cessation
- 1984-01-27 JP JP59013234A patent/JPS59141564A/ja active Pending
- 1984-01-27 YU YU00142/84A patent/YU14284A/xx unknown
- 1984-01-27 PL PL1984245931A patent/PL142340B1/pl unknown
- 1984-01-27 DK DK038984A patent/DK162985C/da active
-
1985
- 1985-10-03 US US06/783,686 patent/US4721711A/en not_active Expired - Fee Related
-
1988
- 1988-08-18 AU AU21421/88A patent/AU652118B2/en not_active Ceased
-
1990
- 1990-11-19 SG SG936/90A patent/SG93690G/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK162985C (da) | Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker paa centralnervesystemet, fremgangsmaade til fremstilling heraf og laegemidler med indhold heraf | |
| EP0201741A3 (en) | Dipeptide derivatives, processes for preparing them, pharmaceutical composition and use | |
| NO841465L (no) | 20-spiroksaner og analoge med aapnet ring e, fremgangsmaate til deres fremstilling samt farmasoeytiske preparater herav | |
| AU7895687A (en) | Catechol derivatives, and preventive and remedial preparations for regressive disorders in the central nervous system containing the same | |
| PH21029A (en) | Benzene derivatives, pharmaceutical compositions and method of use thereof | |
| DK210483D0 (da) | Pyrogallolderivater, deres anvendelse og fremgangsmade til fremstilling deraf | |
| EP0211363A3 (en) | 3-phenylthiomethylstyrene derivative, process for preparing the same, and antiallergic agent and tyrosinekinase inhibiting agent containing the same | |
| DK212784A (da) | Ergolinderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler med indhold heraf | |
| DK418684D0 (da) | Farmaceutiske midler indeholdende pyridazinonderivater, fremgangsmaade til fremstilling heraf samt mellemprodukter derfor | |
| DK409886A (da) | Azolyl-cyclopropyl-ethanol-derivater, fremgangsmaade til deres fremstilling og deres anvendelse | |
| DK536488A (da) | Alkadienderivater, fremgangsmaade og mellemprodukter til deres fremstilling samt laegemidler deraf | |
| ZA842695B (en) | Triazine derivatives,processes for preparation thereof and pharmaceutical compositions comprising the same | |
| DK165985C (da) | 1-cytosinderivater, fremgangsmaader til deres fremstilling, samt anvendelse af dem i og til fremstilling af laegemidler | |
| NO822796L (no) | Aminoorganoaminosilaner, fremgangsmaate til deres fremstilling og deres anvendelse | |
| DK303688D0 (da) | Polyoxygenerede labdanderivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler | |
| NO860733L (no) | N-(2-klor-4-trifluormethylfenyl)-3-trifluormethyl-benzensulfonamidderivat, fremgangsmaate for fremstilling av dette, og fungicid middel inneholdende dette. | |
| DK16982A (da) | Sisomicin-derivater fremgangsmaade til fremstilling heraf samt deres anvendelse som laegemidler | |
| DK361288D0 (da) | Hydroxyethylazolylderivater, deres fremstilling og anvendelse samt mellemprodukter til fremstilling og disses fremstilling | |
| DK136784A (da) | Pyrazolo(1,5-a)pyridinderivater samt fremgangsmaade til fremstilling deraf | |
| DK617684A (da) | 1,3-dioxolanylderivater, fremgangsmaade til deres fremstilling, deres anvendelse og laegemidler indeholdende disse forbindelser | |
| DK136684D0 (da) | Pyrazolo(1,5-a)pyridinderivater samt fremgangsmaade til fremstilling deraf | |
| FI852105A7 (fi) | Asyloidut sokerijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö. | |
| DK260884D0 (da) | 7-oxo-4-thia-1-azabicyclo(3.2.0)-hept-2-en-derivater,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler | |
| DE3466686D1 (en) | Pyrrolidinones potent on the central nervous system, process for their preparation and medicines containing them | |
| HUT40621A (en) | Process for production of derivatives of guanidin, e.g. linoglyride and the intermediers |